p9zny4yk

Property	Value
?:abstract	BACKGROUND: Idiopathic pulmonary fibrosis is a kind of diffuse interstitial lung disease, the pathogenesis of which is unclear, and there is currently a lack of good treatment to improve the survival rate. Human menstrual blood-derived mesenchymal stem cells (MenSCs) have shown great potential in regenerative medicine. This study aimed to explore the therapeutic potential of MenSCs for bleomycin-induced pulmonary fibrosis. METHODS: We investigated the transplantation of MenSCs in a pulmonary fibrosis mouse model induced by BLM. Mouse was divided into three groups: control group, BLM group, MenSC group. Twenty-one days after MenSC transplantation, we examined collagen content, pathological, fibrosis area in the lung tissue, and the level of inflammatory factors of serum. RNA sequence was used to examine the differential expressed gene between three groups. Transwell coculture experiments were further used to examine the function of MenSCs to MLE-12 cells and mouse lung fibroblasts (MLFs) in vitro. RESULTS: We observed that transplantation of MenSCs significantly improves pulmonary fibrosis mouse through evaluations of pathological lesions, collagen deposition, and inflammation. Transwell coculturing experiments showed that MenSCs suppress the proliferation and the differentiation of MLFs and inhibit the apoptosis of MLE-12 cells. Furthermore, antibody array results demonstrated that MenSCs inhibit the apoptosis of MLE-12 cells by suppressing the expression of inflammatory-related cytokines, including RANTES, Eotaxin, GM-CSF, MIP-1γ, MCP-5, CCL1, and GITR. CONCLUSIONS: Collectively, our results suggested MenSCs have a great potential in the treatment of pulmonary fibrosis, and cytokines revealed in antibody array are expected to become the target of future therapy of MenSCs in clinical treatment of pulmonary fibrosis.
is ?:annotates of	<https://research.tib.eu/covid-19/entity/p9zny4yk_hasAnnotation_C0016059> <https://research.tib.eu/covid-19/entity/p9zny4yk_hasAnnotation_C0017337> <https://research.tib.eu/covid-19/entity/p9zny4yk_hasAnnotation_C0021368> <https://research.tib.eu/covid-19/entity/p9zny4yk_hasAnnotation_C0162327> <https://research.tib.eu/covid-19/entity/p9zny4yk_hasAnnotation_C1420810> <https://research.tib.eu/covid-19/entity/p9zny4yk_hasAnnotation_C3540820>
?:creator	<https://research.tib.eu/covid-19/entity/Chen%2C_Xin%3B_Wu%2C_Yi%3B_Wang%2C_Yanling%3B_Chen%2C_Lijun%3B_Zheng%2C_Wendi%3B_Zhou%2C_Sining%3B_Xu%2C_Huikang%3B_Li%2C_Yifei%3B_Yuan%2C_Li%3B_Xiang%2C_Charlie>
?:doi	10.1186/s13287-020-01926-x
?:doi	<https://research.tib.eu/covid-19/entity/10.1186/s13287-020-01926-x>
?:externalLink	<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656201/>
?:journal	Stem_Cell_Res_Ther
?:license	cc-by
?:pdf_json_files	document_parses/pdf_json/60c53cbdd26c8bb32ad08d5a3b2d75e1d0cebdea.json
?:pmc_json_files	document_parses/pmc_json/PMC7656201.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7656201>
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/p9zny4yk_HAS_C0005740_CAUSES_C0034069>
?:sha_id	<https://research.tib.eu/covid-19/entity/60c53cbdd26c8bb32ad08d5a3b2d75e1d0cebdea>
?:source	PMC
?:title	Human menstrual blood-derived stem cells mitigate bleomycin-induced pulmonary fibrosis through anti-apoptosis and anti-inflammatory effects
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-11

Property

Value

?:abstract

BACKGROUND: Idiopathic pulmonary fibrosis is a kind of diffuse interstitial lung disease, the pathogenesis of which is unclear, and there is currently a lack of good treatment to improve the survival rate. Human menstrual blood-derived mesenchymal stem cells (MenSCs) have shown great potential in regenerative medicine. This study aimed to explore the therapeutic potential of MenSCs for bleomycin-induced pulmonary fibrosis. METHODS: We investigated the transplantation of MenSCs in a pulmonary fibrosis mouse model induced by BLM. Mouse was divided into three groups: control group, BLM group, MenSC group. Twenty-one days after MenSC transplantation, we examined collagen content, pathological, fibrosis area in the lung tissue, and the level of inflammatory factors of serum. RNA sequence was used to examine the differential expressed gene between three groups. Transwell coculture experiments were further used to examine the function of MenSCs to MLE-12 cells and mouse lung fibroblasts (MLFs) in vitro. RESULTS: We observed that transplantation of MenSCs significantly improves pulmonary fibrosis mouse through evaluations of pathological lesions, collagen deposition, and inflammation. Transwell coculturing experiments showed that MenSCs suppress the proliferation and the differentiation of MLFs and inhibit the apoptosis of MLE-12 cells. Furthermore, antibody array results demonstrated that MenSCs inhibit the apoptosis of MLE-12 cells by suppressing the expression of inflammatory-related cytokines, including RANTES, Eotaxin, GM-CSF, MIP-1γ, MCP-5, CCL1, and GITR. CONCLUSIONS: Collectively, our results suggested MenSCs have a great potential in the treatment of pulmonary fibrosis, and cytokines revealed in antibody array are expected to become the target of future therapy of MenSCs in clinical treatment of pulmonary fibrosis.

is ?:annotates of